FDA Approves Antiviral Remdesivir to Treat COVID-19
The FDA has approved the very first treatment for COVID-19, and the drugmaker has donated their “entire supply.”
The FDA has approved the very first treatment for COVID-19, and the drugmaker has donated their “entire supply.”
The drug President Trump has often touted as a treatment for COVID-19, despite it being, as yet, unproven, is set to begin a Phase III clinical trial.
Executives from some of the world’s largest pharmaceutical and biotechnology companies met with President Trump to discuss the timeline of a coronavirus vaccine.
Where are you most valued? We’ve ranked the states offering the most generous average annual salaries for nine popular roles within biopharma.
A report from the FDA’s Drug Shortages Task Force has found that there is no one single cause for drug shortages, nor an easy solution to stop them.
The EpiPen drug maker has reached a settlement over a lawsuit with the Securities and Exchange Commission.
Members of Congress received almost $4 million from pharmaceutical manufacturers and their trade groups in the first half of 2019.
According to a new poll, even the U.S. federal government is more well-liked by Americans than the pharmaceutical industry.
All eyes were on Oklahoma last week, when the first case in a flood of litigation against opioid drug manufacturers began Tuesday.
Headlines proclaimed a potential game changer in treating cardiovascular disease—Vascepa—and company shares quickly soared, but the study behind the claim remains a mystery.